Shu-Lan Yuan
About
In The Last Decade
Shu-Lan Yuan
18 papers receiving 513 citations
Peers
Comparison fields: 5 of 71
- Molecular Biology 349
- Complementary and alternative medicine 326
- Pharmacology 124
- Pharmacology 74
- Plant Science 62
Countries citing papers authored by Shu-Lan Yuan
This map shows the geographic impact of Shu-Lan Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu-Lan Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu-Lan Yuan more than expected).
Fields of papers citing papers by Shu-Lan Yuan
This network shows the impact of papers produced by Shu-Lan Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu-Lan Yuan. The network helps show where Shu-Lan Yuan may publish in the future.
Co-authorship network of co-authors of Shu-Lan Yuan
This figure shows the co-authorship network connecting the top 25 collaborators of Shu-Lan Yuan. A scholar is included among the top collaborators of Shu-Lan Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu-Lan Yuan. Shu-Lan Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Reversal of the malignant phenotypes by tanshinone II_A in human breast cancer MCF-7 cell lines and its molecular mechanism | 1 |
| 2 | [Study of molecular mechanism of tanshinone II A inducing differentiation in acute promyelocytic leukemia NB4 cells]. | 3 |
| 3 | 6 | |
| 4 | 67 | |
| 5 | 203 | |
| 6 | [Alteration of activities of telomerase in tanshinone IIA inducing apoptosis of the leukemia cells]. | 14 |
| 7 | 113 | |
| 8 | 10 | |
| 9 | [Anticancer effect of tanshinone and its mechanisms]. | 27 |
| 10 | 11 | |
| 11 | Influence of nimodipine on elimination of soman in rabbit blood and distribution of [3H]soman in mice. | 3 |
| 12 | [Identification of the metabolites of penehyclidine hydrochloride raceme in rats by LC-MS/MS and ion cluster]. | 4 |
| 13 | [A study on apoptosis of nasopharyngeal carcinoma cell line induced by Tanshinone II A and its molecular mechanism]. | 6 |
| 14 | 4 | |
| 15 | 2 | |
| 16 | 19 | |
| 17 | 23 | |
| 18 | 4 | |
| 19 | [Pharmacodynamics and pharmacokinetics of dihydroetorphine hydrochloride administered sublingually in mice and rats]. | 7 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.